COH.AX - Cochlear Limited

ASX - ASX Delayed price. Currency in AUD

Cochlear Limited

1 University Avenue
Macquarie University
Sydney, NSW 2109
61 2 9428 6555

IndustryMedical Devices
Full-time employees4,500

Key executives

NameTitlePayExercisedYear born
Mr. Diggory William Howitt BE (Hons), MBACEO, MD, Pres & Exec. Director3.88M348.04k1967
Mr. Stuart SayersChief Financial Officer1.47MN/AN/A
Mr. Jan Janssen MSc Elec EngChief Technology Officer1.63M50.59k1966
Mr. Anthony BishopPres of Asia Pacific & Latin America1.22M15.48kN/A
Ms. Lisa AubertPres of North America973kN/AN/A
Mr. Richard Brook MBAPres of EMEA1.82M44.25kN/A
Ms. Karen O'DriscollChief Information OfficerN/AN/AN/A
Ms. Kristina DevonVP of Investor RelationsN/AN/AN/A
Ms. Jennifer StevensonVP of Corp. Communications & BrandN/AN/AN/A
Mr. Dean PhizackleaSr. VP of Global Strategic MarketingN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.


Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.

Corporate governance

Cochlear Limited’s ISS governance QualityScore as of 1 May 2023 is 1. The pillar scores are Audit: 1; Board: 5; Shareholder rights: 6; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.